Mahmoud Alghamri

Employment

• University of Michigan Hospital Research Fellow
  2016 - Present
• Wright State University Post Doctoral research Fellow
  2016 - 2016
• Good Samaritan Hospital Pharmacy Intern
  2014 - 2016

Education

• Ohio Board of Pharmacy R.Ph.
  2016 - Present
• Wright State University Boonshoft School of Medicine Ph.D.
  2013 - 2016
• Wright State University Masters
  2010 - 2012

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models
  Santiago Haase, Kaushik Banerjee, Anzar Mujeeb +23 more
  Journal of Clinical Investigation 2022 DOI: 10.1172/JCI154229
  +Save
• G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy
  Mahmoud S. Alghamri, Brandon L. McClellan, Ruthvik Avvari +26 more
  Science Advances 2021 DOI: 10.1126/sciadv.abh3243
  +Save
• Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice
  Journal of Clinical Investigation 2021 DOI: 10.1172/JCI139542
  +Save
• A novel miR1983-TLR7-IFNβ circuit licenses NK cells to kill glioma cells, and is under the control of galectin-1
  Diana Shah, Andrea Comba, Syed Mohd Faisal +8 more
  OncoImmunology 2021 DOI: 10.1080/2162402X.2021.1939601
  +Save
• Immunotherapy for gliomas: shedding light on progress in preclinical and clinical development
  María Belén Garcia-Fabiani, Maria Ventosa, Andrea Comba +13 more
  Expert Opinion on Investigational Drugs 2020 DOI: 10.1080/13543784.2020.1768528
  +Save
• Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1
  Neuro-Oncology Advances 2020 DOI: 10.1093/noajnl/vdaa042
  +Save
• IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response
  Science Translational Medicine 2019 DOI: 10.1126/scitranslmed.aaq1427
  +Save